Evidence map›Paper›PMID 36377597›Full record

ArticleInternational journal of immunopathology and pharmacology

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.

Han-Qing Liu, Wei-Xin Li, Ya-Wen An, Tao Wu, Guang-Yu Jiang, Yu Dong, Wei-Xin Chen, Jian-Chun Wang, Cheng Wang, Shuo Song

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Han-Qing LiuCentral Laboratory, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Wei-Xin LiDepartment of Neurosurgery, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Ya-Wen AnCentral Laboratory, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Tao WuDepartment of Neurosurgery, 74573Peking University Shenzhen Hospital, Shenzhen, P.R. China.
Guang-Yu JiangDepartment of Neurosurgery, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Yu DongDepartment of Neurosurgery, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Wei-Xin ChenCentral Laboratory, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Jian-Chun WangCentral Laboratory, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Cheng WangDepartment of Neurosurgery, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.
Shuo SongCentral Laboratory, 560852Shenzhen Samii Medical Center, Shenzhen, P.R. China.ORCID 0000-0001-6224-2302
Shenzhen Genoimmune Medical Institute · CNPeking University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsGliomaGenomicsHumansIsocitrate DehydrogenaseMutationPrognosisTumor Suppressor Protein p53IDH1 protein, humanIsocitrate DehydrogenaseTP53 protein, humanTumor Suppressor Protein p53Gliomasisocitrate dehydrogenase-1mutationsurvival possibilitytumor protein 53

Identifiers

PMID36377597
PMCPMC9669701
OpenAlexW4309508627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.